Alumis (ALMS) Tax Provisions (2024 - 2025)
Alumis' (ALMS) quarterly Tax Provisions came in at -$39000.0 in Q4 2025, up 99.94% year-on-year from -$19506.2 in Q4 2024, and up 99.54% on a QoQ basis from -$8.6 million in Q2 2025.
Alumis (ALMS) Tax Provisions (2024 - 2025) Analysis & Trends
Alumis (ALMS) has 2 years of Tax Provisions data on file, last reported at -$39000.0 in Q4 2025.
- On a quarterly basis, Tax Provisions rose 99.94% year-over-year to -$39000.0 in Q4 2025; TTM through Dec 2025 was -$70.4 million, a N/A change from a year earlier, with the FY2025 full-year figure at -$8.6 million, up 86.08% from the prior year.
- Tax Provisions for Q4 2025 stood at -$39000.0, up from -$8.6 million in the prior quarter.
- Over the last five years, Tax Provisions for ALMS reached as high as -$39000.0 in Q4 2025 and fell as low as -$61.8 million in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 125,146.46 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -859,000.00 |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 31.86 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 221.50 Mn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 104.00 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | -60.00 Mn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Alumis | 2.37 Bn | 2.06 Bn | - | -39,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -39,000.00 |
| Jun 30, 2025 | -8.56 Mn |
| Dec 31, 2024 | -61.79 Mn |